StockNews.com Begins Coverage on Nektar Therapeutics (NASDAQ:NKTR)
StockNews.com initiated coverage on shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) in a research note published on Tuesday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Several other analysts also recently issued reports on the stock. JPMorgan Chase & Co. reissued an underweight rating on shares of Nektar Therapeutics in […]
More Stories
Pebblebrook Hotel Trust (NYSE:PEB) CEO Jon E. Bortz Purchases 13,000 Shares
Pebblebrook Hotel Trust (NYSE:PEB – Get Free Report) CEO Jon E. Bortz purchased 13,000 shares of the company’s stock in...
Altria Group, Inc. (NYSE:MO) Stock Holdings Lowered by Pitcairn Co.
Pitcairn Co. lowered its position in shares of Altria Group, Inc. (NYSE:MO – Free Report) by 12.8% in the 3rd...
Agrify Announces Completion of $25.9 Million Non-Brokered Private Placement
Agrify Corporation (NASDAQ: AGFY) recently finalized Securities Purchase Agreements with institutional and accredited investors for a non-brokered private placement transaction....
Addentax Group (NASDAQ: ATXG) Signs MOU with Yingbin Brand for Strategic Collaboration
Addentax Group Corp. announced on November 21, 2024, the signing of a memorandum of understanding (MOU) with Shenzhen Yingbin Brand...
TScan Therapeutics (NASDAQ:TCRX) Receives Notice for Conversion of $15 Million Loan into Common Stock
TScan Therapeutics, Inc. recently disclosed in an 8-K filing to the Securities and Exchange Commission that the company has received...
TKO Group Holdings, Inc. Refinances Existing Credit Agreement
TKO Group Holdings, Inc. (NYSE: TKO) announced on November 21, 2024, that its subsidiary, UFC Holdings, LLC, entered into the...